Connect your AI

Celldex Therapeutics CLDX Total Assets

Total Assets at other companies

Eli LillyLLY

$116.58B+30.4%

PfizerPFE

$207.62B-0.2%

Rogers CorporationROG

$1.43B-5.6%

AmgenAMGN

$92.5B+3.5%

Regeneron PharmaceuticalsREGN

$40.87B+8.9%

IncyteINCY

$7.34B+27.7%

Other financials

Income statement

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Cash flow

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Celldex Therapeutics's total assets?: Celldex Therapeutics (CLDX) reported total assets of $511.25M in Q1 2026.
How has Celldex Therapeutics's total assets changed year-over-year?: Celldex Therapeutics's total assets decreased by 30.9% year-over-year, from $739.47M to $511.25M.
What is the long-term trend for Celldex Therapeutics's total assets?: Over 5 years (2020 to 2025), Celldex Therapeutics's total assets has grown at a 19.8% compound annual growth rate (CAGR), from $235.84M to $582.98M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.